Questions to Ask Before Starting Any New Treatment — A Guide for Parents of Children With Autism, PANS, and PANDAS
⚠️ Definition: Every new treatment recommendation — whether conventional or biomedical, whether from a mainstream specialist or an integrative practitioner — deserves the same careful evaluation before a family commits to it. Knowing which specific questions to ask, how to interpret the answers, and what the absence of a clear answer tells you are practical skills that protect families from wasted resources, harmful interventions, and the opportunity cost of pursuing the wrong treatment while the right one goes untried.
Last reviewed by Mary Margaret Burch, FNP-BC — March 2026
Something new has been recommended for your child. Maybe it is a medication. Maybe it is a supplement protocol. Maybe it is a dietary intervention, a specialized therapy, an immune treatment, or a testing panel that will cost several hundred dollars and whose results will require interpretation by someone you have not yet met. The provider presenting it believes in it — or at least appears to. Other families in your support network have tried it. The website looks credible.
And you are trying to decide whether to do it.
The pressure in this moment is real. Your child is struggling. You want to help. The thing being recommended might be the thing that finally moves the needle. And the fear of saying no — of passing up something that might have helped — can be as powerful as the fear of saying yes to something that will not.
What cuts through that pressure is not more research in the middle of the night. It is a set of specific, direct questions that any provider recommending a treatment should be able to answer — and whose answers, or whose absence, tell you what you need to know.
This page gives you those questions. All of them. Organized by category. With the explanation of why each one matters and what the answer should look like from a provider whose recommendation is worth following.
The Foundational Question — Before Anything Else
Before asking about the treatment itself, there is one question that should precede all others. It is the question that determines whether the entire conversation that follows is grounded in your child's specific biology or in a general approach being applied broadly.
"What specific finding in my child's individual evaluation indicates that this treatment is appropriate for them?"
A provider who can answer this question specifically — naming a laboratory finding, a clinical observation, a symptom pattern, or a biological marker that connects this child's individual picture to this specific intervention — is a provider who has done the individualized assessment that responsible treatment requires.
A provider who cannot answer it specifically — who responds with general statements about how this treatment helps children with autism or PANS and PANDAS broadly, without connecting it to what is actually happening in this child's biology — has not done that assessment. The treatment is being recommended on the basis of the diagnosis rather than the individual. That is a meaningful distinction, and it is worth naming directly before proceeding.
This question applies to every treatment — conventional and biomedical, expensive and inexpensive, familiar and novel. A psychiatrist recommending a medication, a biomedical provider recommending a supplement protocol, a specialist recommending an immune intervention — all of them should be able to answer this question specifically for your child.
Category 1 — Questions About the Evidence
These questions establish what is actually known about the treatment — not what is claimed, not what testimonials suggest, but what the clinical and research evidence actually shows.
"What does the evidence show for this treatment — specifically for children with my child's condition and biological profile?"
The answer should distinguish between what the evidence shows for a specific population under specific conditions and what is claimed more broadly. A probiotic with strong evidence for children with documented gut dysbiosis is not the same clinical situation as an emerging IV therapy with preliminary results in a small case series. Both may have a role — but they are not in the same evidential category, and the provider should not present them as if they are.
"How strong is the evidence — are we talking about randomized controlled trials, case series, clinical experience, or something else?"
Different types of evidence carry different weights. A randomized controlled trial produces more reliable conclusions than a case series. A case series produces more reliable conclusions than anecdotal clinical experience. Clinical experience produces more reliable conclusions than testimonials. A provider who can articulate what type of evidence supports their recommendation — and who is honest about the limitations of that evidence — is a provider engaging with the question seriously.
"Is this treatment recommended by any mainstream medical bodies, and if not, why not?"
The absence of mainstream endorsement is not automatically a red flag — many evidence-informed approaches in complex pediatric conditions have not yet been formally endorsed by mainstream bodies. But a provider should be able to explain why — whether the evidence is emerging and not yet reviewed, whether there are institutional barriers to recognition, or whether the approach is genuinely controversial within the clinical community. An honest answer to this question is more valuable than a defensive one.
"What does the research show about who does NOT respond to this treatment?"
This question reveals whether the provider is presenting a complete picture or a curated one. Every treatment that works for some children does not work for others — and the characteristics of non-responders are as clinically important as the characteristics of responders. A provider who can describe both is presenting an honest picture. A provider who can only describe the positive outcomes is presenting marketing.
Category 2 — Questions About Risks and Side Effects
These questions establish what could go wrong — not to create fear, but to ensure that the decision is made with the complete picture rather than only the potential upside.
"What are the known risks and side effects of this treatment for children in my child's age group and with my child's specific conditions?"
The answer should be specific to pediatric patients and specific to any relevant conditions your child has. A medication that has a well-characterized side effect profile in adults may have a different profile in children. An intervention that is generally safe may carry specific risks for children with immune dysregulation, gut dysfunction, or mitochondrial concerns. The provider should know the relevant distinctions and present them honestly.
"Are there any known interactions between this treatment and my child's current medications or supplements?"
This question requires the provider to engage with your child's current treatment picture rather than evaluating the new intervention in isolation. Bring your master clinical summary — with the complete current medication and supplement list — to this conversation. A provider who reviews that list before answering this question is doing their job. A provider who answers without reviewing it is not.
"What are the signs that this treatment is causing harm rather than helping, and what should we do if we observe them?"
Every treatment that can produce benefit can also produce harm in specific circumstances. A provider who has thought about what adverse responses look like — and who can give you specific, observable signs to watch for and a clear protocol for what to do if you see them — is a provider who is taking responsibility for the treatment rather than only the recommendation.
"What happens if we start this treatment and then need to stop — is there a withdrawal process, and what does it look like?"
Some treatments cannot be stopped abruptly without a tapering process. Some have rebound effects when discontinued. Some require a specific discontinuation protocol to prevent harm. A provider who knows the answer to this question has thought about the full arc of the treatment, not only the initiation.
Category 3 — Questions About What Success Looks Like
These questions establish how you will know whether the treatment is working — before it begins, not after weeks of uncertainty about whether what you are observing means anything.
"What specific improvements should we expect to see, and in what timeframe?"
The answer should be specific enough to be observable. Not "your child may seem calmer" — but "we would expect to see a reduction in the frequency of raging episodes within four to six weeks, and we would expect sleep quality to improve within the first two weeks." Vague improvement language is not a benchmark. Specific, observable, time-bound outcomes are.
"How will we measure whether this is working?"
The measurement method should exist before the treatment begins. Whether it is a flare tracker, a behavioral log, a laboratory follow-up, a standardized rating scale, or a specific clinical observation — there should be a plan for how the question "is this working?" will be answered with something other than subjective impression.
"What is the minimum response we would expect to see to consider continuing this treatment?"
This question establishes the floor — the minimum evidence of benefit that justifies continuing. A treatment that is not producing at least the minimum expected response within the expected timeframe is a treatment worth reconsidering. Having that floor established in advance prevents the indefinite continuation of interventions that are not helping, driven by the hope that more time will eventually produce results.
"When will we formally review whether to continue, adjust, or stop?"
A specific review date — not "we'll see how it goes" but "we will formally evaluate at the six-week mark and make a decision about whether to continue" — creates accountability for both the provider and the family. It prevents treatment drift — the gradual accumulation of interventions that are never formally evaluated and never formally discontinued.
📊 The treatment evaluation checklist — complete before starting anything new:
- What specific finding in my child's evaluation indicates this is appropriate for them?
- What does the evidence show — for this specific population, at what level of evidence quality?
- What are the known risks and side effects specific to my child's profile?
- Are there interactions with current medications or supplements?
- What specific improvements should we see, and in what timeframe?
- How will we measure whether it is working?
- What is the minimum response that justifies continuing?
- When will we formally review the decision to continue?
- What does stopping look like if we need to discontinue?
- What is the total expected cost, and what does insurance cover?
Category 4 — Questions About Cost and Logistics
These questions address the practical reality that families in this situation are managing — financial resources that are not unlimited, time and energy that are not unlimited, and the opportunity cost of pursuing one intervention while another goes untried.
"What is the total expected cost of this treatment course — including all appointments, testing, and the intervention itself?"
The full cost picture is often not presented upfront. A supplement protocol with a modest monthly cost may require quarterly laboratory monitoring that adds significantly to the total. An IV treatment may require multiple sessions and follow-up testing. Knowing the full expected cost before committing — not just the cost of the first appointment or the first month — is essential for making a financially informed decision.
"What does insurance cover, and what will we be paying out of pocket?"
This question requires the provider's office to check specifically rather than give a general answer. Insurance coverage for complex pediatric interventions is highly variable and often requires prior authorization, documentation of medical necessity, and sometimes appeals. Knowing what is covered before committing — and what the out-of-pocket exposure is if coverage is denied — is part of informed decision-making.
"Are there less expensive alternatives with comparable evidence that we should consider first?"
This question reflects the principle that responsible biomedical care begins with the least expensive, most biologically matched intervention — not the most intensive or most expensive one. A provider who can honestly answer this question — who can say "yes, there is a less expensive approach that addresses the same biological factor and is worth trying first" — is a provider whose priority is your child rather than their revenue. A provider who resists or dismisses this question is worth evaluating carefully.
When the Answers Are Not Good Enough
The questions above are designed to produce clear, specific, honest answers from providers who have done the work required to make responsible recommendations. When the answers are not clear, not specific, or not honest — when a provider deflects, generalizes, or responds to direct questions with pressure or defensiveness — that response is itself information.
A provider who cannot answer "what specific finding in my child's evaluation indicates this is appropriate for them" has not done the individualized assessment the question presupposes. A provider who cannot articulate specific, time-bound benchmarks for evaluating whether the treatment is working does not have a plan for monitoring outcomes. A provider who responds to questions about evidence with testimonials rather than clinical reasoning is not engaging with the question seriously.
None of this requires confrontation. Asking these questions in a genuinely curious tone — "I want to make sure I understand what we are doing and why" — is not adversarial. It is appropriate engagement with a consequential decision. A provider who responds to that genuine curiosity with defensiveness or dismissal is telling you something important about how they operate.
The right answer to these questions does not need to be perfect. Providers working in complex, emerging areas of pediatric medicine are working with genuine uncertainty, and honest acknowledgment of that uncertainty — "the evidence here is preliminary, here is what we know and what we don't" — is more trustworthy than false certainty in either direction. What the answers need to be is honest, specific, and grounded in this child's individual picture rather than in general claims about what the treatment does.
💬 If this framework is clicking for you and you're tired of piecing things together from random posts and forums, consider joining the Spectrum Care Hub Learning Community. You'll get full access to step-by-step biomedical coursework, printable tools, and new lessons added every month. Click here for details
Frequently Asked Questions
What if I ask these questions and the provider gets defensive? Defensiveness in response to reasonable clinical questions is worth noting. A provider who is confident in their recommendation and committed to your child's outcomes welcomes these questions — they are evidence of an engaged clinical partner. A provider who responds to "what does the evidence show" with frustration or pressure has told you something important about how accountable they are willing to be. That information belongs in your evaluation of whether to proceed.
Is it rude to ask a specialist these questions? No. These are the questions any informed patient or patient advocate should ask before committing to any significant medical intervention. Providers who are doing their jobs well have already thought about the answers. Providers who have not thought about the answers needed to think about them before making the recommendation. Asking respectfully and with genuine curiosity is appropriate regardless of the provider's specialty or seniority.
What if the treatment has already been recommended by multiple providers? Multiple providers recommending the same treatment increases the signal that it may be appropriate — but it does not substitute for the specific evaluation that connects the treatment to this child's individual biological picture. Multiple providers can all be applying a general approach rather than an individualized one. The questions on this page are still worth asking, even when the recommendation is coming from multiple sources.
How do I evaluate a treatment I found through my own research rather than a provider recommendation? Apply the same framework. What does the evidence show for this specific intervention in a specific population? What are the risks? What would a provider need to find in my child's evaluation to indicate it is appropriate for them? What are the benchmarks for success? The source of the treatment idea — whether it comes from a provider, a parent group, or your own research — does not change what questions need to be answered before pursuing it.
My child has been on a treatment for a long time and we have never formally evaluated whether it is working. What do we do? Schedule a formal review with the prescribing or recommending provider. Use the benchmarks framework — what were we expecting to see, have we seen it, and is the current benefit worth the ongoing cost, risk, and logistical demand of continuing? It is never too late to evaluate whether something is working. The treatments that families continue indefinitely without evaluation are often the ones that stopped producing meaningful benefit long before anyone asked the question.
💬 If this helped you see your child's behavior and biology in a new light, the next step is to keep building on that clarity. Our Spectrum Care Hub subscription gives you the complete course library, deeper dive modules, and ongoing support, so you don't have to navigate autism and PANS/PANDAS care alone. Click here for details
Last reviewed by Mary Margaret Burch, FNP-BC — March 2026 © 2026 Spectrum Care Hub LLC / SpectrumCareHub.com. This article is for educational purposes only. Nothing here constitutes medical advice or creates a provider-patient relationship. Always work with a qualified, licensed healthcare provider before making any medical decisions for your child.